Liu Dongfang 4
4 · Nuvation Bio Inc. · Filed May 6, 2025
Insider Transaction Report
Form 4
Liu Dongfang
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Class A Common Stock
2025-05-02$1.94/sh+20,000$38,800→ 32,000 total - Sale
Class A Common Stock
2025-05-02$2.50/sh−20,000$50,024→ 12,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-05-02$1.94/sh−20,000$38,800→ 480,000 totalExercise: $1.94Exp: 2033-02-27→ Class A Common Stock (20,000 underlying)
Footnotes (3)
- [F1]Shares sold pursuant to a 10b5-1 plan dated October 10, 2024.
- [F2]Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.50 to $2.505. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]Option vests as to 25% on 2/28/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date